Gwn Securities »

Neuropace shares owned by Gwn Securities

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Gwn Securities from 13F filings

Historical chart of Gwn Securities investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Gwn Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Gwn Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $298k 23k 13.15

More positions owned by Gwn Securities

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Innovator Etfs Trust Laddered Alc Bfr (BUFB)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Ultra Short Dur (ICSH)
Innovator Etfs Trust Laderd Alctn Pwr (BUFF)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Johnson & Johnson (JNJ)
Vanguard World Inf Tech Etf (VGT)
Cardinal Health (CAH)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Gwn Securities

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
Geode Capital Management
FMR
State Street Corporation
Silvercrest Asset Management Group
Northern Trust

View all funds holding Neuropace